Hung, T., Tsai, C., Tseng, C., Tseng, K., Hsieh, Y., & Tsai, C. (2016). No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment. Lippincott Williams And Wilkins.

Hung, Tsung-Hsing, Chen-Chi Tsai, Chih-Wei Tseng, Kuo-Chih Tseng, Yu-Hsi Hsieh, and Chih-Chun Tsai. No Difference in Mortality between Terlipressin and Somatostatin Treatments in Cirrhotic Patients With Esophageal Variceal Bleeding and Renal Functional Impairment. Lippincott Williams And Wilkins, 2016.

Hung, Tsung-Hsing, et al. No Difference in Mortality between Terlipressin and Somatostatin Treatments in Cirrhotic Patients With Esophageal Variceal Bleeding and Renal Functional Impairment. Lippincott Williams And Wilkins, 2016.